1. Home
  2. PLX vs ONEG Comparison

PLX vs ONEG Comparison

Compare PLX & ONEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLX
  • ONEG
  • Stock Information
  • Founded
  • PLX 1993
  • ONEG 2021
  • Country
  • PLX United States
  • ONEG Hong Kong
  • Employees
  • PLX N/A
  • ONEG N/A
  • Industry
  • PLX Biotechnology: Biological Products (No Diagnostic Substances)
  • ONEG Homebuilding
  • Sector
  • PLX Health Care
  • ONEG Consumer Discretionary
  • Exchange
  • PLX Nasdaq
  • ONEG Nasdaq
  • Market Cap
  • PLX 164.2M
  • ONEG 181.8M
  • IPO Year
  • PLX 1998
  • ONEG 2024
  • Fundamental
  • Price
  • PLX $2.60
  • ONEG $12.15
  • Analyst Decision
  • PLX Strong Buy
  • ONEG
  • Analyst Count
  • PLX 1
  • ONEG 0
  • Target Price
  • PLX $15.00
  • ONEG N/A
  • AVG Volume (30 Days)
  • PLX 792.6K
  • ONEG 296.4K
  • Earning Date
  • PLX 11-13-2025
  • ONEG 01-01-0001
  • Dividend Yield
  • PLX N/A
  • ONEG N/A
  • EPS Growth
  • PLX N/A
  • ONEG N/A
  • EPS
  • PLX 0.08
  • ONEG 0.08
  • Revenue
  • PLX $61,948,000.00
  • ONEG $53,205,000.00
  • Revenue This Year
  • PLX $14.53
  • ONEG N/A
  • Revenue Next Year
  • PLX $75.77
  • ONEG N/A
  • P/E Ratio
  • PLX $33.57
  • ONEG $153.43
  • Revenue Growth
  • PLX 62.79
  • ONEG N/A
  • 52 Week Low
  • PLX $0.99
  • ONEG $1.48
  • 52 Week High
  • PLX $3.10
  • ONEG $13.50
  • Technical
  • Relative Strength Index (RSI)
  • PLX 82.14
  • ONEG 59.84
  • Support Level
  • PLX $1.52
  • ONEG $11.00
  • Resistance Level
  • PLX $2.12
  • ONEG $11.82
  • Average True Range (ATR)
  • PLX 0.12
  • ONEG 0.84
  • MACD
  • PLX 0.05
  • ONEG -0.12
  • Stochastic Oscillator
  • PLX 96.79
  • ONEG 69.23

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

About ONEG OneConstruction Group Limited Ordinary Shares

OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.

Share on Social Networks: